SCHEMBL29560293

SCHEMBL29560293

COc1cc(N2CCN(C)CC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccc(C)c(C)c2P(C)C)n1

nearest known ligand 0.58

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 7/20 0.58
▸ INSR P06213 3/20 0.58
▸ IGF1R P08069 3/20 0.58
▸ EGFR P00533 8/20 0.56
▸ BRD4 O60885 3/20 0.56
▸ JAK3 P52333 1/20 0.54
▸ AXL P30530 1/20 0.51
▸ MAP3K7 O43318 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22942149 0.93 INSR (0.69) ALKINSRIGF1REGFR
SCHEMBL22942878 0.91 ALK (0.63) ALKINSRIGF1REGFR
SCHEMBL29559900 0.91 ALK (0.63) ALKINSRIGF1REGFR
SCHEMBL22942141 0.86 EGFR (0.69) ALKINSRIGF1REGFR
SCHEMBL22943345 0.86 EGFR (0.56) ALKINSRIGF1REGFR
SCHEMBL22942163 0.86 INSR (0.60) ALKINSRIGF1REGFR
SCHEMBL22942156 0.85 INSR (0.61) ALKINSRIGF1REGFR
SCHEMBL24179137 0.84 ALK (0.73) ALKINSRIGF1REGFR
SCHEMBL24179052 0.81 INSR (0.69) ALKINSRIGF1REGFR
SCHEMBL22942226 0.81 EGFR (0.56) ALKINSRIGF1REGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114430740-B EGFR inhibitors, compositions and methods of making the same 贝达药业股份有限公司 2023-12-29 — — CN claimed
CN-114430740-A EGFR inhibitor, composition and preparation method thereof 贝达药业股份有限公司 2022-05-03 — — CN claimed
CN-114430740-B EGFR inhibitors, compositions and methods of making the same 贝达药业股份有限公司 2023-12-29 — — CN disclosed
CN-114430740-A EGFR inhibitor, composition and preparation method thereof 贝达药业股份有限公司 2022-05-03 — — CN disclosed
Send feedback